Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study

International Journal of Biological Macromolecules
Anam KhanKhalid Khan

Abstract

The present study was designed to develop and optimize Temozolomide nano lipid chitosan hydrogel formulations (TMZNLCHG) to target the brain through nasal route. The formulation was developed using chitosan as a gelling agent and Vit E: gelucire 44/14 blend as lipid. The formulations were evaluated for particle size, encapsulation efficiency (%EE), drug loading (DL), morphology, drug release, nasal diffusion, cell line study, and histopathology study. The particle size, PDI, %EE, %DL, and drug release were found to be 134 nm, 0.177, 88.45% ± 4.45%, 9.12% ± 0.78%, and 84.23% ± 2.78%, respectively. The enhancement ratio was more than two folds higher than TMZCHG formulation (control) suggesting the superiority of chitosan with lipid as permeability enhancer. The microscopic image of lyophilized TMZNLCHGopt displayed the spherical and rough surface morphology. IC50 was found to be 3.34 μg/ml for TMZNLCHGopt and was 160 μg/ml for pure TMZ. Further, No structural damage was observed with TMZNLCHGopt treated nasal mucosa upon histopathological examination. Overall, the present study produces encouraging findings in the formulation of a non-invasive intranasal route for brain targeting as an alternate to other route for TMZ.

Citations

Feb 1, 2019·Drug Development and Industrial Pharmacy·Dnyandev G Gadhave, Chandrakant R Kokare
Feb 20, 2019·Pharmaceutics·Franciele Aline BruinsmannFabio Sonvico
May 24, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gregor KravanjaMaja Leitgeb
Apr 7, 2020·Biotechnology and Applied Biochemistry·AmirHossein BahmanpourMasoud Mozafari
Nov 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Franciele Aline BruinsmannFabio Sonvico
May 21, 2020·Frontiers in Bioengineering and Biotechnology·Doddy Denise Ojeda-HernándezJuan C Mateos-Díaz
Sep 3, 2020·Membranes·Hernán CortésGerardo Leyva-Gómez
Jan 4, 2020·AAPS PharmSciTech·Xin FengMuhammad Ashraf
Aug 21, 2018·Frontiers in Pharmacology·Simona SestitoSimona Rapposelli
Dec 10, 2020·Pharmaceutics·Manuela CurcioFrancesca Iemma
Dec 18, 2020·Expert Opinion on Drug Delivery·Ebrahim MostafaviThomas J Webster
May 1, 2021·Pharmaceutics·Tianqi WangJie Shen
Nov 14, 2020·International Journal of Biological Macromolecules·Dnyandev GadhaveChandrakant Kokare
Jul 7, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·P Soma YasaswiKhushwant S Yadav
Jul 25, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wei WuHeike E Daldrup-Link
Sep 2, 2020·Current Pharmaceutical Design·Mohammed Asadullah JahangirSadaf Jamal Gilani

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.